Study Objectives: Sepsis was redefined as "life-threatening organ dysfunction caused by a dysregulated host response to infection" in 2016. As the concept of systemic inflammatory response was superseded, a new clinical criterion for identifying patients with high risk of organ dysfunction -the quick Sepsis-related Organ Failure Assessment (qSOFA) score -was recommended. qSOFA consists of 3 criteria: altered mentation, tachypnoea (respiratory rate 22 bpm) and hypotension (systolic blood pressure 100mmHg). The aim of this systematic review was to study the existing evidence to determine the predictive value of qSOFA for prognosis of sepsis in the emergency department.
¼98.8%, 95% CI 98.6-99.0). Conclusions: qSOFA is a poor predictor of in-hospital mortality. For screening scores or systems to be useful in the ED setting, the sensitivity of the tool should be high to ensure that potentially critically ill patients are not missed. qSOFA may be a useful predictor of organ dysfunction according to Seymour et al, but it is not a reliable score for clinically screening patients for in-hospital mortality. Study Objectives: To determine the sensitivity of bedside use of a highly sensitive leukocyte esterase colorimetric reagent strip (RS) for detection of spontaneous bacterial peritonitis (SBP) in emergency department (ED) patients undergoing paracentesis.
Methods: We conducted a prospective, observational cohort study of ED patients with ascites undergoing paracentesis at 2 academic facilities. Two practitioners, blinded to each other's results, did a bedside RS analysis of the peritoneal fluid in each patient and documented the RS reading at 3-minutes according to manufacturer specifications as either "negative," "trace," "small," or large." The primary outcome measure was sensitivity of the RS strip for SBP at both the "trace" threshold (positive equals "trace" or greater) and "small" threshold (positive equals "small" or greater). SBP was defined as an absolute neutrophil count (ANC) >¼ 250 cells/mm 3 . Results: There were 282 patients who had 330 paracentesis fluid samples enrolled, with 635 fluid analyses performed. Of these, 40 fluid samples had SBP (6%). Bedside RS had a sensitivity of 95% (95% CI 82%-99%) at the "trace" threshold and 85% (95% CI 69%-94%) at the "small" threshold for the detection of SBP. There were important limitations. First, the inclusion criterion was that the provider believed that fluid analysis was indicated to exclude SBP in that patient. Thus, it is possible that we missed SBP cases by excluding those in which the clinician felt that fluid analysis was not indicated. However, both study EDs were involved in 2 previous research studies which demonstrated that physician clinical suspicion, without fluid analysis, was inadequate in ruling out SBP, so standard practice at each of these facilities was peritoneal fluid laboratory analysis. Second, approximately 38% of patients who received a paracentesis were not enrolled in the study. However, chart review of 25 non-enrolled patients demonstrated that only 2 patients (8%) had SBP, similar to the incidence of SBP in enrolled patients. Third, we did not reach our goal number of SBP patients, thus generating larger confidence intervals for our primary outcome. This was due to the lower incidence of SBP in this study compared to 2 prior studies in the same hospitals (12% in previous studies).
Conclusions: Lack of equipment and specialized personnel in smaller hospitals, and the delay associated with peritoneal fluid testing in a busy ED setting, make a RS with the ability to rapidly rule out SBP at the bedside an attractive option. Under the best conditions, using a threshold of "trace" positive at 3 minutes, the Periscreen RS demonstrated a high sensitivity of 95%. However, the wide confidence interval surrounding the sensitivity limits our ability to recommend the RS as a stand-alone test to rule out SBP. With previous studies demonstrating patients thought to be at low risk of SBP had a lower incidence of SBP, future studies examining the combination of low clinical suspicion and a negative RS bedside result at the "trace" threshold may permit the safe discharge of nearly half of low suspicion patients without laboratory testing.
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